Rhabdomyolysis plus Hypocalcemia and Diabetic Ketoacidosis as Concurrent Rare COVID-19 Manifestations

Maryam Heidarpour; Mehrbod Vakhshoori; Mohammad Ali Haghighatpanah; Leila Ashrafi; Farzin Khorvash; Bijan Iraj

doi:10.1155/2021/6625086

Rhabdomyolysis plus Hypocalcemia and Diabetic Ketoacidosis as Concurrent Rare COVID-19 Manifestations

Case Rep Med. 2021 Mar 8:2021:6625086. doi: 10.1155/2021/6625086. eCollection 2021.

Authors

Maryam Heidarpour¹, Mehrbod Vakhshoori², Mohammad Ali Haghighatpanah³, Leila Ashrafi¹, Farzin Khorvash⁴, Bijan Iraj¹

Affiliations

¹ Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
² Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
³ Isfahan University of Medical Sciences, Isfahan, Iran.
⁴ Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Background: Common manifestations of coronavirus disease 2019 (COVID-19) from its initial official introduction are mostly related to the respiratory system. However, other rarer presentations are reported nowadays. Case Presentations. We reported three cases of COVID-19-infected patients with rhabdomyolysis as well as two other rarer simultaneous signs, including hypocalcemia (Case 1) and diabetic ketoacidosis (DKA) (Case 2).

Conclusion: Despite the fact that rhabdomyolysis is an infrequent manifestation of COVID-19, high clinical suspicion is required for proper diagnosis and management of this disease as well as other concurrent rarer presentations, including hypocalcemia and DKA for the prevention of further complications.

Publication types

Case Reports